Ticker Symbol: OXNXF

Onxeo SA

Exchange: US OTC Country: FR Currency: USD Asset Type: Common Stock

Company Profile

Onxeo SA is a is a clinical-stage biotechnology company. It engages in the development of drugs for the treatment of orphan diseases. The firm produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Gilles Avenard and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.

Sector: Health Technology

Industry: Biotechnology

Standard Industrial Classification Code (SIC code): 2834

Address: 49, blvd. du Général Martial Valin

Website: http://www.onxeo.com

CEO: Judith Greciet

Tags:

Biotechnology
Health Technology

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $0.67 - $0.85

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 111507130

Valuation

Market Cap: 7.5B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A